Heinrich Dreismann - Net Worth and Insider Trading

Heinrich Dreismann Net Worth

The estimated net worth of Heinrich Dreismann is at least $3 Million dollars as of 2024-10-01. Heinrich Dreismann is the Director of Myriad Genetics Inc and owns about 121,648 shares of Myriad Genetics Inc (MYGN) stock worth over $3 Million. Details can be seen in Heinrich Dreismann's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Heinrich Dreismann has not made any transactions after 2024-09-09 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of Heinrich Dreismann

Heinrich Dreismann Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Heinrich Dreismann owns 4 companies in total, including Ignyta Inc (RXDX) , Interpace Biosciences Inc (IDXG) , and Myriad Genetics Inc (MYGN) among others .

Click here to see the complete history of Heinrich Dreismann’s form 4 insider trades.

Insider Ownership Summary of Heinrich Dreismann

Ticker	Comapny	Transaction Date	Type of Owner
RXDX	Ignyta Inc	2018-02-08	director
IDXG	Interpace Biosciences Inc	2014-08-13	director
MYGN	Myriad Genetics Inc	2024-09-09	director
		2023-05-19	director

Heinrich Dreismann Latest Holdings Summary

Heinrich Dreismann currently owns a total of 1 stock. Heinrich Dreismann owns 121,648 shares of Myriad Genetics Inc (MYGN) as of September 9, 2024, with a value of $3 Million.

Latest Holdings of Heinrich Dreismann

Ticker	Comapny	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
MYGN	Myriad Genetics Inc	2024-09-09	121,648	27.39	3,331,939

Holding Weightings of Heinrich Dreismann

Heinrich Dreismann Form 4 Trading Tracker

According to the SEC Form 4 filings, Heinrich Dreismann has made a total of 1 transactions in Myriad Genetics Inc (MYGN) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Myriad Genetics Inc is the sale of 10,000 shares on September 9, 2024, which brought Heinrich Dreismann around $270,500.

Insider Trading History of Heinrich Dreismann

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Heinrich Dreismann Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Heinrich Dreismann Ownership Network

Ownership Network List of Heinrich Dreismann

No Data

Ownership Network Relation of Heinrich Dreismann

Heinrich Dreismann Owned Company Details

What does Ignyta Inc do?

Who are the key executives at Ignyta Inc?

Heinrich Dreismann is the director of Ignyta Inc. Other key executives at Ignyta Inc include Chief Medical Officer Pratik S Multani , director & 10 percent owner & President & CEO & Director Jonathan E Lim , and Chief Financial Officer Jacob Chacko .

Ignyta Inc (RXDX) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Ignyta Inc (RXDX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Ignyta Inc (RXDX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Ignyta Inc (RXDX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Ignyta Inc Insider Transactions

No Available Data

What does Interpace Biosciences Inc do?

Who are the key executives at Interpace Biosciences Inc?

Heinrich Dreismann is the director of Interpace Biosciences Inc. Other key executives at Interpace Biosciences Inc include Principal Financial Officer Christopher Mccarthy , director & President and CEO Thomas W. Burnell , and 10 percent owner Peter H Kamin .

Interpace Biosciences Inc (IDXG) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Interpace Biosciences Inc (IDXG) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Interpace Biosciences Inc (IDXG) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Interpace Biosciences Inc (IDXG)'s detailed insider trading history can be found in Insider Trading Tracker table.

Interpace Biosciences Inc Insider Transactions

No Available Data

What does Myriad Genetics Inc do?

Who are the key executives at Myriad Genetics Inc?

Heinrich Dreismann is the director of Myriad Genetics Inc. Other key executives at Myriad Genetics Inc include Chief Scientific Officer Dale Muzzey , director & President and CEO Paul J Diaz , and SVP & Chief of Staff Margaret Ancona .

Myriad Genetics Inc (MYGN) Insider Trades Summary

Over the past 18 months, Heinrich Dreismann made 1 insider transaction in Myriad Genetics Inc (MYGN) with a net sale of 10,000. Other recent insider transactions involving Myriad Genetics Inc (MYGN) include a net sale of 242,844 shares made by Paul J Diaz , a net sale of 60,000 shares made by Richard Bryan Riggsbee , and a net sale of 16,214 shares made by Daniel K Spiegelman .

In summary, during the past 3 months, insiders sold 92,150 shares of Myriad Genetics Inc (MYGN) in total and bought 0 shares, with a net sale of 92,150 shares. During the past 18 months, 402,408 shares of Myriad Genetics Inc (MYGN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 402,408 shares.

Myriad Genetics Inc (MYGN)'s detailed insider trading history can be found in Insider Trading Tracker table.

Myriad Genetics Inc Insider Transactions

No Available Data

What does Talis Biomedical Corp do?

Who are the key executives at Talis Biomedical Corp?

Heinrich Dreismann is the director of Talis Biomedical Corp. Other key executives at Talis Biomedical Corp include President & other: Chief Scientific Officer Andrew A Lukowiak , Interim CFO Rebecca Markovich , and director & 10 percent owner Julian Baker .

Talis Biomedical Corp (TLIS) Insider Trades Summary

Over the past 18 months, Heinrich Dreismann made no insider transaction in Talis Biomedical Corp (TLIS). Other recent insider transactions involving Talis Biomedical Corp (TLIS) include a net purchase of 45,133 shares made by Braden Michael Leonard ,

In summary, during the past 3 months, insiders sold 0 shares of Talis Biomedical Corp (TLIS) in total and bought 45,133 shares, with a net purchase of 45,133 shares. During the past 18 months, 0 shares of Talis Biomedical Corp (TLIS) were sold and 45,133 shares were bought by its insiders, resulting in a net purchase of 45,133 shares.

Talis Biomedical Corp (TLIS)'s detailed insider trading history can be found in Insider Trading Tracker table.

Talis Biomedical Corp Insider Transactions

No Available Data

Heinrich Dreismann Mailing Address

Above is the net worth, insider trading, and ownership report for Heinrich Dreismann. You might contact Heinrich Dreismann via mailing address: 320 Wakara Way, Salt Lake City Ut 84108.

Discussions on Heinrich Dreismann

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.